American Heart Journal
Volume 144, Issue 6 , Pages 1018-1025 , December 2002

Risks and benefits of early treatment of acute myocardial infarction with an angiotensin-converting enzyme inhibitor in patients with a history of arterial hypertension: Analysis of the GISSI-3 database

Received 3 April 2001 ,Accepted 4 February 2002.

References 

  1. Pfeffer MA, Braunwald E, Moyé LA, et al.  Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the Survival and Ventricular Enlargement Trial. N Engl J Med. 1992;327:669–677
  2. Acute Infarction Ramipril Efficacy (AIRE) Study Investigators . Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet. 1993;342:821–828
  3. Kober L, Torp-Pedersen C, Carlsen JE, et al.  A clinical trial of the angiotensin converting enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 1995;333:1670–1676
  4. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico . GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet. 1994;343:1115–1122
  5. ISIS-4 Collaborative Group . ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58050 patients with suspected acute myocardial infarction. Lancet. 1995;345:669–685
  6. Chinese Cardiac Study Collaborative Group . Oral captopril versus placebo among 13,634 patients with suspected acute myocardial infarction: interim report from Chinese Cardiac Study (CCS-1). Lancet. 1995;345:686–687
  7. ACE Inhibitor Myocardial Infarction Collaborative Group. Indications for ACE Inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100000 patients in randomized trials. Circulation. 1998;97:2202–2212
  8. Pfeffer MA. ACE inhibitors in acute myocardial infarction: patient selection and timing. Circulation. 1998;97:2192–2194
  9. Latini R, Maggioni AP, Flather M, et al.  ACE Inhibitor use in patients with myocardial infarction. Circulation. 1995;92:3132–3137
  10. Cruickshank JM, Thorp JM, Zacharias FJ. Benefits and potential harm of lowering high blood pressure. Lancet. 1987;1:581–584
  11. D'Agostino RB, Belanger AJ, Kannel WB, et al.  Relation of low diastolic blood pressure to coronary heart disease death in presence of myocardial infarction: the Framingham study. BMJ. 1991;303:385–389
  12. GISSI-3 Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico . GISSI-3 study protocol on the effects of lisinopril, of nitrates, and of their association in patients with acute myocardial infarction. Am J Cardiol. 1992;70:62C–69C
  13. Yusuf S, Peto R, Lewis J, et al.  Beta blockade during and after myocardial infarction: an overview of the randomized trial. Prog Cardiovasc Dis. 1985;27:335–371
  14. Kaplan EL, Meier P. Nonparametric estimation from incomplete observational. J Am Stat Assoc. 1958;53:457–481
  15. Cox DR. Regression models and life tables. J R Stat Soc B. 1972;34:187–203
  16. Hosmer DW, Lemeshow S. Applied logistic regression. New York: John Wiley & Sons;; 1989;
  17. Peto R, Pike MC, Armitage P, et al.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I: introduction and design. Br J Cancer. 1976;34:585–612
  18. Herlitz J, Karison BW, Richter A, et al.  Prognosis in hypertensives with acute myocardial infarction. J Hypertens. 1992;10:1265–1271
  19. Fresco C, Avanzini F, Bosi S, et al.  Prognostic value of a history of hypertension in 11483 patients with acute myocardial infarction treated with thrombolysis. J Hypertens. 1996;14:743–750
  20. Gustafsson F, Kober L, Torp-Pedersen C, et al.  Long-term prognosis after acute myocardial infarction in patients with a history of arterial hypertension. Eur Heart J. 1998;19:588–594
  21. Farnett L, Mulrow CD, Linn WD, et al.  The J-Curve phenomenon and the treatment of hypertension: is there a point beyond which pressure reduction is dangerous?. JAMA. 1991;265:489–495
  22. Pepi M, Alimento M, Maltagliati A, et al.  Cardiac hypertrophy in hypertension: repolarization abnormalities elicited by rapid lowering of pressure. Hypertension. 1988;11:84–91
  23. Collins P, Cruickshank JM, Keegan J, et al.  Acute blood pressure reduction causes an impairment of left ventricular function in hypertensive patients with coronary heart disease and left ventricular hypertrophy [abstract]. Eur Heart J. 1991;12:242
  24. Cruickshank JM. The role of coronary perfusion pressure. Eur Heart J. 1992;13(D Suppl):39–43
  25. Polese A, De Cesare N, Montorsi P, et al.  Upward shift of the lower range of coronary flow autoregulation in hypertensive patients with hypertrophy of the left ventricle. Circulation. 1991;83:845–853
  26. Flack JM, Neaton J, Grimm R, et al.  Blood pressure mortality among men with prior myocardial infarction. Circulation. 1995;92:2437–2445
  27. Hansson L, Zanchetti A, Carruthers SG, et al.  Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet. 1998;351:1755–1762
  28. Kaplan N. J-curve not burned off by HOT study. Lancet. 1998;351:1748–1749
  29. Latini R, Avanzini F, De Nicolao A, et al.  Effects of lisinopril and nitroglycerin on blood pressure early after myocardial infarction: the GISSI-3 pilot study. Clin Pharmacol Ther. 1994;56:680–692

 Supported by the Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO) and by the Istituto di Ricerche Farmacologiche Mario Negri (IRFMN).

☆☆ *A complete list of collaborators and participating centers appeared in Lancet 1994;343:1115-22.

 Reprint requests: GISSI Coordinating Centre, Via Eritrea 62, 20157 Milano, Italy.

★★ E-mail: avanzini@marionegri.it

PII: S0002-8703(02)00226-0

doi: 10.1067/mhj.2002.126739

American Heart Journal
Volume 144, Issue 6 , Pages 1018-1025 , December 2002